# BridgeBio Pharma, Inc.: Form DEF 14A, filed Apr 30, 2021

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: DEF 14A
- Filed: 2021-04-30
- Accepted by EDGAR: Apr 30, 2021, 17:05 ET
- Period: 2021-06-17
- Accession: 0001193125-21-145491
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm

Filed Apr 30, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-145491. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
